close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

1.330 -0.130 (-8.90%)
Official Closing Price Updated: 8:00 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Calidi Biotherapeutics, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Study Highlights Increasing Cases of Breast Cancer in Younger Women
Via Investor Brand Network
Study Proposes Overhaul of US Lung Cancer Screening Guidelines
Via Investor Brand Network
News headline image
Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Via ACCESS Newswire
Cancer Immunotherapy Could Be Boosted by Targeting Pathways of DNA Repair
Via Investor Brand Network
What Patients Need to Know About Exercising During Cancer Treatment
Via Investor Brand Network
Study Suggests mRNA Covid Vaccine Could Boost Cancer Immunotherapy
Via Investor Brand Network
Study identifies Biomarker to Predict Success of Immunotherapy, Chemo for Breast Cancer
Via Investor Brand Network
Rarest Natural Element Promises to Revolutionize How Cancer is Treated
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
Cancer Immunotherapy Could Be Transformed by Boosting Natural Killer Cells
Via Investor Brand Network
Lung Cancer Screening is Still Woefully Low in the US, Report Shows
Via Investor Brand Network
Topics Death
New LED Therapy Kills Cancer Cells While Sparing Healthy Tissues
Via Investor Brand Network
Researchers Urge Canadians to Donate Toenails, for Science
Via Investor Brand Network
Researchers Discover Why Cancer Immunotherapy Could Be Failing
Via Investor Brand Network
Lund University Researchers Discover Why Leukemia Cells Evade the Immune System
Via Investor Brand Network
Researchers Find That Common Nutrient Could Supercharge the Immune Cells Fighting Cancer
Via Investor Brand Network
How Patients Can Boost Dietary Nutrient Intake During Cancer Treatment
Via Investor Brand Network
Study Finds That Common Sweetener Could Compromise Cancer Treatment Effectiveness
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) to Present at H.C. Wainwright Global Investment Conference
Via Investor Brand Network
New Study Discovers Unexpected Reason for Resistance to Cancer Immunotherapy
Via Investor Brand Network
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option
Via Investor Brand Network
Scientists Turn Bacteria into Trojan Horses to Deliver Anti-Cancer Viruses into Tumors
Via Investor Brand Network
News headline image
Which stocks are experiencing notable movement on Wednesday? ↗
Stay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Nasdaq Down 1%; Lowe's Posts Upbeat Earnings ↗
 
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Prices $6 Million Public Offering
Via Investor Brand Network
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Wednesday. 
Via Chartmill
News headline image
Dow Surges 100 Points; Target Shares Fall After Q2 Results ↗
 
Via Benzinga
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today